I wouldn't be surprised if we get the cut and paste response from previous reports. "Decreasing birth rates in China are putting downward pressure on demand"
We shouldn't expect to see that though, given that they weren't hasty about trying to enter the US market......
Ann: Deferral of FDA consideration of enforcement discretion, page-64
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$7.05 |
Change
0.200(2.92%) |
Mkt cap ! $5.096B | |||
| Open | High | Low | Value | Volume |
| $6.90 | $7.05 | $6.89 | $9.342M | 1.335M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 5662 | $7.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $7.05 | 43467 | 7 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| A2M (ASX) Chart |